0000950170-24-088659.txt : 20240731 0000950170-24-088659.hdr.sgml : 20240731 20240731164543 ACCESSION NUMBER: 0000950170-24-088659 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240715 FILED AS OF DATE: 20240731 DATE AS OF CHANGE: 20240731 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shook David CENTRAL INDEX KEY: 0001959742 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 241162664 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1150 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (925) 407-1049 MAIL ADDRESS: STREET 1: 1150 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 ownership.xml 4 X0508 4 2024-07-15 0001787400 Nkarta, Inc. NKTX 0001959742 Shook David C/O NKARTA, INC. 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 false true false false See Remarks false Common Stock 2024-07-15 4 A false 23421 0 A 139945 D Stock Option (right to buy) 7.02 2024-07-15 4 A false 30000 0 A 2034-07-14 Common Stock 30000 30000 D This transaction is inadvertently filed late due to an administrative error. Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on August 20, 2025. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 15, 2024. Chief Medical Officer, Head of Research & Development /s/ Alicia Hager, as Attorney-in-Fact 2024-07-31